Kelly Elise Dooley

Associate Professor

20022019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Kelly Elise Dooley is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 29 Similar Profiles
Tuberculosis Medicine & Life Sciences
rifapentine Medicine & Life Sciences
Rifampin Medicine & Life Sciences
Pharmacokinetics Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
bedaquiline Medicine & Life Sciences
Multidrug-Resistant Tuberculosis Medicine & Life Sciences
efavirenz Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2019

Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology

Dooley, K. E., Hanna, D., Mave, V., Eisenach, K. & Savic, R. M., Jul 1 2019, In : PLoS medicine. 16, 7, p. e1002842

Research output: Contribution to journalArticle

Open Access
Clinical Pharmacology
Microbiology
Tuberculosis

Adverse outcome pathway for aminoglycoside ototoxicity in drug-resistant tuberculosis treatment

Hong, H., Dooley, K. E., Starbird, L. E., Francis, H. W. & Farley, J., Jan 1 2019, In : Archives of Toxicology.

Research output: Contribution to journalArticle

Multidrug-Resistant Tuberculosis
Aminoglycosides
Audition
Hearing Loss
Oxidative stress

Alternative dosing guidelines to improve outcomes in childhood tuberculosis: a mathematical modelling study

Radtke, K. K., Dooley, K. E., Dodd, P. J., Garcia-Prats, A. J., McKenna, L., Hesseling, A. C. & Savic, R. M., Sep 1 2019, In : The Lancet. Child & adolescent health. 3, 9, p. 636-645 10 p.

Research output: Contribution to journalArticle

Tuberculosis
Guidelines
Rifampin
Weights and Measures
Nutritional Status

Antiretroviral switching and bedaquiline treatment of drug-resistant tuberculosis HIV co-infection

O'Donnell, M. R., Padayatchi, N., Daftary, A., Orrell, C., Dooley, K. E., Rivet Amico, K. & Friedland, G., Mar 1 2019, In : The Lancet HIV. 6, 3, p. e201-e204

Research output: Contribution to journalComment/debate

bedaquiline
Multidrug-Resistant Tuberculosis
Coinfection
HIV Infections
efavirenz
Open Access
Rifampin
Anti-Infective Agents
Mycobacterium tuberculosis
Positron-Emission Tomography
Names